Contractors / Astrazeneca Pharmaceuticals LP
Astrazeneca Pharmaceuticals LP
prime recipient of federal awards · UEI E5K2ZJ8CTJH4 ✓ from source
$590.7M
obligated · FY2022
3
funding agencies
98%
from Defense
0%
single-source
2
states
2
industries
≈ computedSingle-source: 0% of this recipient’s $575.9M in federal contracts was awarded without competition (FPDS extent-competed codes); the rest was competed or unclassified. A high share often reflects sole-source or specialized work, not wrongdoing.
Obligations by year
≈ computed$495.7M
FY20
$502.1M
FY21
$590.7M
FY22
▲ 19%
since FY20
Where this money comes from
✓ from sourceFUNDING AGENCIES
ASTRAZENECA PHARMACEUTIC
Defense
$0.6B
2 other agencies
$0B
Astrazeneca Pharmaceuticals LP
$0.6B
FY2022 obligated
Biggest awards (total value)
awarded 2020$1.1B
Total value over each award’s life, for awards active in FY2022: a decades-long contract can exceed one year’s obligations above.
What it does (NAICS / PSC)
Where the work lands
Oklahoma✓ from source$29.3K
Competitors
No competitors computed.
Corporate family
Single registration: no combined family.
🔎
Why the labels? The graph is only worth anything if the links are trusted. Facts taken straight from a federal filing are ✓ from source; figures we calculate are ≈ computed; links we infer (corporate parents, districts, competitors, connections between records) are ≈ inferred, worded carefully, never asserted as fact and never a claim that one thing caused another. Spot an error? Tell us.